vaccine– tag –
-
Oncology Drug
KRAS Cancer Vaccine Competitive Map: 4 Modalities Compared After Moderna/Merck V941’s Withdrawal
Takeaway: the field is coalescing around shared neoantigens × off-the-shelf × adjuvant MRD. Elicio (ELI-002 7P) leads the pack; academic SLP + poly-ICLC programs and Gritstone’s SLATE-KRAS follow. With V941 halted, the landscape is clear... -
Oncology FDA Approval
CD388 (Cidara): What “One-Shot Seasonal Flu Protection” Could Mean for Vaccine Strategy
A New Era in Flu Prevention? — CD388 Shows One-Shot Seasonal Protection Introduction Flu prevention has long relied on seasonal vaccines, but a new innovation may challenge that paradigm. CD388, a long-acting antiviral developed by Cidar... -
Biotech Investment
Biotech Investment News: GSK’s Major Deals from 2015 to 2025
Strategic Review: Focused Expansion in Vaccines and Specialty Medicines Over the past decade, GSK has shifted from large-scale M&A to focused investments and strategic partnerships, particularly in vaccines, oncology, respiratory, an...
1